nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—ORM1—bile—celiac disease	0.0659	0.0716	CbGeAlD
Erlotinib—UGT1A1—urine—celiac disease	0.0467	0.0508	CbGeAlD
Erlotinib—ORM1—saliva—celiac disease	0.043	0.0467	CbGeAlD
Erlotinib—JAK3—connective tissue—celiac disease	0.0261	0.0283	CbGeAlD
Erlotinib—NR1I2—digestive system—celiac disease	0.0236	0.0256	CbGeAlD
Erlotinib—CYP1A2—urine—celiac disease	0.0207	0.0225	CbGeAlD
Erlotinib—FLT3—connective tissue—celiac disease	0.0206	0.0223	CbGeAlD
Erlotinib—JAK3—lymphoid tissue—celiac disease	0.0191	0.0207	CbGeAlD
Erlotinib—JAK3—digestive system—celiac disease	0.0188	0.0205	CbGeAlD
Erlotinib—ORM1—gall bladder—celiac disease	0.0183	0.0199	CbGeAlD
Erlotinib—JAK3—blood—celiac disease	0.0179	0.0195	CbGeAlD
Erlotinib—NR1I2—liver—celiac disease	0.0176	0.0191	CbGeAlD
Erlotinib—TNK1—blood—celiac disease	0.0165	0.0179	CbGeAlD
Erlotinib—ALB—gall bladder—celiac disease	0.016	0.0174	CbGeAlD
Erlotinib—PIP4K2C—pancreas—celiac disease	0.0157	0.0171	CbGeAlD
Erlotinib—FLT3—lymphoid tissue—celiac disease	0.015	0.0163	CbGeAlD
Erlotinib—CYP3A4—urine—celiac disease	0.015	0.0163	CbGeAlD
Erlotinib—CYP2D6—urine—celiac disease	0.0147	0.016	CbGeAlD
Erlotinib—FLT3—blood—celiac disease	0.0142	0.0154	CbGeAlD
Erlotinib—ABL2—blood—celiac disease	0.0135	0.0147	CbGeAlD
Erlotinib—SLK—pancreas—celiac disease	0.0134	0.0145	CbGeAlD
Erlotinib—TNK1—liver—celiac disease	0.0129	0.014	CbGeAlD
Erlotinib—ULK3—digestive system—celiac disease	0.0128	0.0139	CbGeAlD
Erlotinib—PIP4K2C—blood—celiac disease	0.0128	0.0139	CbGeAlD
Erlotinib—MKNK1—lymphoid tissue—celiac disease	0.0122	0.0133	CbGeAlD
Erlotinib—ULK3—blood—celiac disease	0.0122	0.0133	CbGeAlD
Erlotinib—MKNK1—digestive system—celiac disease	0.0121	0.0131	CbGeAlD
Erlotinib—MKNK1—blood—celiac disease	0.0115	0.0125	CbGeAlD
Erlotinib—FLT3—liver—celiac disease	0.0111	0.012	CbGeAlD
Erlotinib—SLK—blood—celiac disease	0.0109	0.0118	CbGeAlD
Erlotinib—ABL2—liver—celiac disease	0.0106	0.0115	CbGeAlD
Erlotinib—EGFR—liver—celiac disease	0.0103	0.0112	CbGeAlD
Erlotinib—STK10—lymphoid tissue—celiac disease	0.0101	0.0109	CbGeAlD
Erlotinib—PIP4K2C—liver—celiac disease	0.01	0.0109	CbGeAlD
Erlotinib—STK10—digestive system—celiac disease	0.00993	0.0108	CbGeAlD
Erlotinib—ULK3—liver—celiac disease	0.00955	0.0104	CbGeAlD
Erlotinib—ABL1—connective tissue—celiac disease	0.00947	0.0103	CbGeAlD
Erlotinib—STK10—blood—celiac disease	0.00946	0.0103	CbGeAlD
Erlotinib—UGT1A1—digestive system—celiac disease	0.00938	0.0102	CbGeAlD
Erlotinib—MKNK1—liver—celiac disease	0.00899	0.00976	CbGeAlD
Erlotinib—UGT1A1—blood—celiac disease	0.00894	0.00971	CbGeAlD
Erlotinib—ABL1—smooth muscle tissue—celiac disease	0.00867	0.00941	CbGeAlD
Erlotinib—SLK—liver—celiac disease	0.00851	0.00924	CbGeAlD
Erlotinib—MAP2K5—blood—celiac disease	0.00845	0.00918	CbGeAlD
Erlotinib—CYP1B1—connective tissue—celiac disease	0.00802	0.00872	CbGeAlD
Erlotinib—ABL1—pancreas—celiac disease	0.00801	0.0087	CbGeAlD
Erlotinib—STK10—liver—celiac disease	0.0074	0.00804	CbGeAlD
Erlotinib—CYP1B1—smooth muscle tissue—celiac disease	0.00734	0.00797	CbGeAlD
Erlotinib—UGT1A1—liver—celiac disease	0.00699	0.00759	CbGeAlD
Erlotinib—ABL1—lymphoid tissue—celiac disease	0.00693	0.00753	CbGeAlD
Erlotinib—SLCO2B1—digestive system—celiac disease	0.0069	0.0075	CbGeAlD
Erlotinib—ORM1—blood—celiac disease	0.00686	0.00745	CbGeAlD
Erlotinib—ABL1—digestive system—celiac disease	0.00684	0.00743	CbGeAlD
Erlotinib—MAP2K5—liver—celiac disease	0.00661	0.00718	CbGeAlD
Erlotinib—ABL1—blood—celiac disease	0.00652	0.00708	CbGeAlD
Erlotinib—CYP1B1—lymphoid tissue—celiac disease	0.00587	0.00637	CbGeAlD
Erlotinib—CYP1B1—digestive system—celiac disease	0.0058	0.0063	CbGeAlD
Erlotinib—CYP1B1—blood—celiac disease	0.00552	0.006	CbGeAlD
Erlotinib—CYP1A1—epithelium—celiac disease	0.00538	0.00585	CbGeAlD
Erlotinib—ORM1—liver—celiac disease	0.00537	0.00583	CbGeAlD
Erlotinib—SLCO2B1—liver—celiac disease	0.00514	0.00559	CbGeAlD
Erlotinib—ABL1—liver—celiac disease	0.0051	0.00554	CbGeAlD
Erlotinib—ALB—liver—celiac disease	0.0047	0.00511	CbGeAlD
Erlotinib—CYP3A5—pancreas—celiac disease	0.00469	0.0051	CbGeAlD
Erlotinib—CYP1B1—liver—celiac disease	0.00432	0.00469	CbGeAlD
Erlotinib—CYP2C8—blood—celiac disease	0.00423	0.00459	CbGeAlD
Erlotinib—CYP1A2—digestive system—celiac disease	0.00415	0.00451	CbGeAlD
Erlotinib—ABCG2—blood—celiac disease	0.00411	0.00447	CbGeAlD
Erlotinib—CYP1A1—digestive system—celiac disease	0.0041	0.00445	CbGeAlD
Erlotinib—CYP3A5—digestive system—celiac disease	0.00401	0.00435	CbGeAlD
Erlotinib—CYP1A2—blood—celiac disease	0.00396	0.0043	CbGeAlD
Erlotinib—CYP1A1—blood—celiac disease	0.0039	0.00424	CbGeAlD
Erlotinib—CYP3A5—blood—celiac disease	0.00382	0.00415	CbGeAlD
Erlotinib—EGFR—Stabilization and expansion of the E-cadherin adherens junction—LPP—celiac disease	0.00355	0.0447	CbGpPWpGaD
Erlotinib—CYP2C8—liver—celiac disease	0.00331	0.00359	CbGeAlD
Erlotinib—ABCG2—liver—celiac disease	0.00321	0.00349	CbGeAlD
Erlotinib—CYP1A2—liver—celiac disease	0.00309	0.00336	CbGeAlD
Erlotinib—CYP1A1—liver—celiac disease	0.00305	0.00332	CbGeAlD
Erlotinib—CYP3A4—digestive system—celiac disease	0.00301	0.00327	CbGeAlD
Erlotinib—JAK3—CD40/CD40L signaling—TNFAIP3—celiac disease	0.00299	0.0376	CbGpPWpGaD
Erlotinib—CYP3A5—liver—celiac disease	0.00298	0.00324	CbGeAlD
Erlotinib—CYP2D6—digestive system—celiac disease	0.00296	0.00321	CbGeAlD
Erlotinib—CYP3A4—blood—celiac disease	0.00286	0.00311	CbGeAlD
Erlotinib—CYP2D6—blood—celiac disease	0.00282	0.00306	CbGeAlD
Erlotinib—ABCB1—epithelium—celiac disease	0.0028	0.00304	CbGeAlD
Erlotinib—JAK3—Signaling events mediated by TCPTP—PTPN2—celiac disease	0.00268	0.0338	CbGpPWpGaD
Erlotinib—ABL1—Regulation of actin dynamics for phagocytic cup formation—MYO9B—celiac disease	0.0026	0.0327	CbGpPWpGaD
Erlotinib—ABCB1—pancreas—celiac disease	0.00249	0.00271	CbGeAlD
Erlotinib—CYP3A4—liver—celiac disease	0.00224	0.00243	CbGeAlD
Erlotinib—CYP2D6—liver—celiac disease	0.0022	0.00239	CbGeAlD
Erlotinib—ABCB1—lymphoid tissue—celiac disease	0.00215	0.00234	CbGeAlD
Erlotinib—ABCB1—digestive system—celiac disease	0.00213	0.00231	CbGeAlD
Erlotinib—ABCB1—blood—celiac disease	0.00203	0.0022	CbGeAlD
Erlotinib—ABL1—Fcgamma receptor (FCGR) dependent phagocytosis—MYO9B—celiac disease	0.00196	0.0247	CbGpPWpGaD
Erlotinib—JAK3—IL4-mediated signaling events—ETS1—celiac disease	0.00196	0.0247	CbGpPWpGaD
Erlotinib—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.00162	0.0204	CbGpPWpGaD
Erlotinib—SLCO2B1—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00159	0.02	CbGpPWpGaD
Erlotinib—ABCB1—liver—celiac disease	0.00159	0.00172	CbGeAlD
Erlotinib—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.00151	0.019	CbGpPWpGaD
Erlotinib—EGFR—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.00147	0.0185	CbGpPWpGaD
Erlotinib—EGFR—Thromboxane A2 receptor signaling—TGM2—celiac disease	0.00145	0.0183	CbGpPWpGaD
Erlotinib—ABCG2—HIF-2-alpha transcription factor network—ETS1—celiac disease	0.00129	0.0163	CbGpPWpGaD
Erlotinib—JAK3—IL4-mediated signaling events—IL10—celiac disease	0.00122	0.0153	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—IL21—celiac disease	0.00121	0.0153	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—MICA—celiac disease	0.00121	0.0153	CbGpPWpGaD
Erlotinib—EGFR—Signaling events mediated by TCPTP—PTPN2—celiac disease	0.00117	0.0148	CbGpPWpGaD
Erlotinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—ETS1—celiac disease	0.00114	0.0143	CbGpPWpGaD
Erlotinib—JAK3—Platelet activation, signaling and aggregation—PLEK—celiac disease	0.00113	0.0142	CbGpPWpGaD
Erlotinib—ABL1—Regulation of actin dynamics for phagocytic cup formation—FCGR2A—celiac disease	0.00108	0.0136	CbGpPWpGaD
Erlotinib—EGFR—Androgen receptor signaling pathway—ZMIZ1—celiac disease	0.00107	0.0134	CbGpPWpGaD
Erlotinib—EGFR—Signaling events mediated by PTP1B—FCGR2A—celiac disease	0.000993	0.0125	CbGpPWpGaD
Erlotinib—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.000931	0.0117	CbGpPWpGaD
Erlotinib—ABL1—Integrated Breast Cancer Pathway—ZMIZ1—celiac disease	0.000817	0.0103	CbGpPWpGaD
Erlotinib—ABL1—Fcgamma receptor (FCGR) dependent phagocytosis—FCGR2A—celiac disease	0.000815	0.0103	CbGpPWpGaD
Erlotinib—SLCO2B1—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000806	0.0101	CbGpPWpGaD
Erlotinib—ABCG2—HIF-1-alpha transcription factor network—ETS1—celiac disease	0.000761	0.00958	CbGpPWpGaD
Erlotinib—MKNK1—Disease—LCT—celiac disease	0.000711	0.00895	CbGpPWpGaD
Erlotinib—EGFR—Integrated Breast Cancer Pathway—ZMIZ1—celiac disease	0.000699	0.00879	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—ARHGAP31—celiac disease	0.000657	0.00827	CbGpPWpGaD
Erlotinib—ALB—Platelet degranulation—PLEK—celiac disease	0.000641	0.00807	CbGpPWpGaD
Erlotinib—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—celiac disease	0.000611	0.00769	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.000594	0.00747	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—PLEK—celiac disease	0.000582	0.00732	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—PTPN2—celiac disease	0.000566	0.00712	CbGpPWpGaD
Erlotinib—MKNK1—Signaling by FGFR—CD80—celiac disease	0.000557	0.00701	CbGpPWpGaD
Erlotinib—ABL1—PDGFR-beta signaling pathway—PTPN2—celiac disease	0.000552	0.00695	CbGpPWpGaD
Erlotinib—ABL1—Factors involved in megakaryocyte development and platelet production—SH2B3—celiac disease	0.000535	0.00673	CbGpPWpGaD
Erlotinib—MKNK1—Signaling by FGFR in disease—CD80—celiac disease	0.000519	0.00654	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—FCGR2A—celiac disease	0.000516	0.00649	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—ARHGAP31—celiac disease	0.000496	0.00624	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—HLA-DPB1—celiac disease	0.000495	0.00623	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—IL12A—celiac disease	0.000483	0.00607	CbGpPWpGaD
Erlotinib—ALB—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.000476	0.00598	CbGpPWpGaD
Erlotinib—JAK3—Immune System—MYO9B—celiac disease	0.000464	0.00584	CbGpPWpGaD
Erlotinib—EGFR—Signaling by SCF-KIT—SH2B3—celiac disease	0.000444	0.00559	CbGpPWpGaD
Erlotinib—JAK3—Immune System—ICOS—celiac disease	0.00044	0.00554	CbGpPWpGaD
Erlotinib—JAK3—Immune System—ICOSLG—celiac disease	0.00042	0.00529	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—HLA-DQA1—celiac disease	0.000413	0.0052	CbGpPWpGaD
Erlotinib—ABCB1—HIF-1-alpha transcription factor network—ETS1—celiac disease	0.000412	0.00518	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—MYO9B—celiac disease	0.000408	0.00514	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—ARHGAP31—celiac disease	0.000404	0.00508	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—MYO9B—celiac disease	0.000398	0.00501	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000392	0.00493	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—HLA-DQB1—celiac disease	0.000386	0.00486	CbGpPWpGaD
Erlotinib—JAK3—Immune System—TNFRSF14—celiac disease	0.000374	0.00471	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—SH2B3—celiac disease	0.000365	0.0046	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—RGS1—celiac disease	0.000361	0.00454	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—MYO9B—celiac disease	0.000349	0.00439	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TAGAP—celiac disease	0.000345	0.00434	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—RGS1—celiac disease	0.000327	0.00412	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—IL17A—celiac disease	0.000326	0.0041	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—ICOS—celiac disease	0.000317	0.004	CbGpPWpGaD
Erlotinib—EGFR—Constitutive PI3K/AKT Signaling in Cancer—CD80—celiac disease	0.000305	0.00384	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—ICOSLG—celiac disease	0.000303	0.00381	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—HLA-DPB1—celiac disease	0.000301	0.00378	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MYO9B—celiac disease	0.0003	0.00378	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—PLEK—celiac disease	0.000298	0.00375	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—HLA-DRB1—celiac disease	0.000294	0.0037	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—CTLA4—celiac disease	0.000285	0.00359	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—PLEK—celiac disease	0.000284	0.00358	CbGpPWpGaD
Erlotinib—MAP2K5—NGF signalling via TRKA from the plasma membrane—CD80—celiac disease	0.000283	0.00356	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—CCR4—celiac disease	0.000279	0.00351	CbGpPWpGaD
Erlotinib—EGFR—PI-3K cascade—CD80—celiac disease	0.000275	0.00346	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—TNFRSF14—celiac disease	0.00027	0.0034	CbGpPWpGaD
Erlotinib—EGFR—PI3K/AKT activation—CD80—celiac disease	0.000268	0.00338	CbGpPWpGaD
Erlotinib—EGFR—GAB1 signalosome—CD80—celiac disease	0.000266	0.00335	CbGpPWpGaD
Erlotinib—EGFR—B Cell Activation—CD79A—celiac disease	0.000261	0.00329	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TAGAP—celiac disease	0.00026	0.00328	CbGpPWpGaD
Erlotinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—CD80—celiac disease	0.00026	0.00327	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—RGS1—celiac disease	0.000257	0.00323	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CCR4—celiac disease	0.000253	0.00319	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—HLA-DQA1—celiac disease	0.000251	0.00316	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MYO9B—celiac disease	0.000245	0.00308	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000242	0.00304	CbGpPWpGaD
Erlotinib—ABL1—Immune System—MYO9B—celiac disease	0.000238	0.00299	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—CCR3—celiac disease	0.000237	0.00298	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—HLA-DQB1—celiac disease	0.000235	0.00295	CbGpPWpGaD
Erlotinib—EGFR—Disease—LCT—celiac disease	0.000235	0.00295	CbGpPWpGaD
Erlotinib—ABL1—Immune System—ICOS—celiac disease	0.000225	0.00284	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—IL10—celiac disease	0.000222	0.00279	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling by NGF—CD80—celiac disease	0.000217	0.00274	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ARHGAP31—celiac disease	0.000217	0.00273	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—LCT—celiac disease	0.000216	0.00272	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CCR3—celiac disease	0.000215	0.00271	CbGpPWpGaD
Erlotinib—ABL1—Immune System—ICOSLG—celiac disease	0.000215	0.00271	CbGpPWpGaD
Erlotinib—JAK3—Immune System—MBL2—celiac disease	0.000213	0.00268	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TAGAP—celiac disease	0.000212	0.00267	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000212	0.00266	CbGpPWpGaD
Erlotinib—EGFR—Signaling by SCF-KIT—CD80—celiac disease	0.000205	0.00259	CbGpPWpGaD
Erlotinib—EGFR—Immune System—MYO9B—celiac disease	0.000203	0.00256	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—LCT—celiac disease	0.000202	0.00254	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CCR4—celiac disease	0.000198	0.0025	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling of activated FGFR—CD80—celiac disease	0.000197	0.00247	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB4—CD80—celiac disease	0.000193	0.00244	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—RGS1—celiac disease	0.000193	0.00243	CbGpPWpGaD
Erlotinib—JAK3—Immune System—FCGR2A—celiac disease	0.000193	0.00243	CbGpPWpGaD
Erlotinib—EGFR—Immune System—ICOS—celiac disease	0.000193	0.00242	CbGpPWpGaD
Erlotinib—ABL1—Immune System—TNFRSF14—celiac disease	0.000192	0.00241	CbGpPWpGaD
Erlotinib—JAK3—Immune System—TNFAIP3—celiac disease	0.000189	0.00238	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—MBL2—celiac disease	0.000187	0.00236	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—SH2B3—celiac disease	0.000187	0.00235	CbGpPWpGaD
Erlotinib—JAK3—Immune System—PTPN2—celiac disease	0.000185	0.00233	CbGpPWpGaD
Erlotinib—EGFR—Downstream signal transduction—CD80—celiac disease	0.000185	0.00233	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR—CD80—celiac disease	0.000184	0.00231	CbGpPWpGaD
Erlotinib—EGFR—Immune System—ICOSLG—celiac disease	0.000184	0.00231	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—LCT—celiac disease	0.000183	0.00231	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB2—CD80—celiac disease	0.000183	0.0023	CbGpPWpGaD
Erlotinib—EGFR—DAP12 signaling—CD80—celiac disease	0.000182	0.00229	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—CD80—celiac disease	0.000179	0.00226	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—HLA-DRB1—celiac disease	0.000178	0.00225	CbGpPWpGaD
Erlotinib—EGFR—Fc epsilon receptor (FCERI) signaling—CD80—celiac disease	0.000171	0.00216	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR in disease—CD80—celiac disease	0.000171	0.00216	CbGpPWpGaD
Erlotinib—EGFR—DAP12 interactions—CD80—celiac disease	0.000171	0.00216	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR—CD80—celiac disease	0.00017	0.00214	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—FCGR2A—celiac disease	0.000169	0.00213	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CCR3—celiac disease	0.000169	0.00212	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR in Cancer—CD80—celiac disease	0.000168	0.00212	CbGpPWpGaD
Erlotinib—EGFR—Signaling by PDGF—CD80—celiac disease	0.000168	0.00211	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—TNFAIP3—celiac disease	0.000166	0.00209	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—CD80—celiac disease	0.000165	0.00207	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—SH2B3—celiac disease	0.000164	0.00207	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TNFRSF14—celiac disease	0.000164	0.00206	CbGpPWpGaD
Erlotinib—JAK3—Immune System—HLA-DPB1—celiac disease	0.000162	0.00203	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—MBL2—celiac disease	0.00016	0.00202	CbGpPWpGaD
Erlotinib—EGFR—B Cell Activation—CD80—celiac disease	0.000159	0.002	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—RGS1—celiac disease	0.000158	0.00198	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CTLA4—celiac disease	0.000153	0.00193	CbGpPWpGaD
Erlotinib—EGFR—NGF signalling via TRKA from the plasma membrane—CD80—celiac disease	0.000152	0.00191	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CCR4—celiac disease	0.00015	0.00188	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—PLEK—celiac disease	0.000147	0.00185	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CD79A—celiac disease	0.000146	0.00184	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—FCGR2A—celiac disease	0.000145	0.00182	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—RGS1—celiac disease	0.000143	0.0018	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—TNFAIP3—celiac disease	0.000142	0.00179	CbGpPWpGaD
Erlotinib—JAK3—Immune System—HLA-DQA1—celiac disease	0.000135	0.0017	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—LCT—celiac disease	0.000131	0.00165	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MYO9B—celiac disease	0.000131	0.00165	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CCR3—celiac disease	0.000127	0.0016	CbGpPWpGaD
Erlotinib—JAK3—Immune System—HLA-DQB1—celiac disease	0.000126	0.00159	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—LCT—celiac disease	0.000124	0.00156	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—SH2B3—celiac disease	0.000124	0.00156	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CCR4—celiac disease	0.000122	0.00153	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CD8A—celiac disease	0.000118	0.00148	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—CD80—celiac disease	0.000117	0.00147	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—HLA-DPB1—celiac disease	0.000117	0.00147	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TAGAP—celiac disease	0.000114	0.00143	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—LCT—celiac disease	0.000114	0.00143	CbGpPWpGaD
Erlotinib—ALB—Metabolism—LCT—celiac disease	0.000113	0.00142	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CCR4—celiac disease	0.000111	0.00139	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CTLA4—celiac disease	0.00011	0.00139	CbGpPWpGaD
Erlotinib—ABL1—Immune System—MBL2—celiac disease	0.000109	0.00137	CbGpPWpGaD
Erlotinib—MKNK1—Disease—CD80—celiac disease	0.000108	0.00137	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD79A—celiac disease	0.000105	0.00133	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CCR3—celiac disease	0.000104	0.0013	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—SH2B3—celiac disease	0.000101	0.00127	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—LCT—celiac disease	9.92e-05	0.00125	CbGpPWpGaD
Erlotinib—ABL1—Immune System—FCGR2A—celiac disease	9.87e-05	0.00124	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—HLA-DQA1—celiac disease	9.73e-05	0.00122	CbGpPWpGaD
Erlotinib—ABL1—Immune System—TNFAIP3—celiac disease	9.69e-05	0.00122	CbGpPWpGaD
Erlotinib—JAK3—Immune System—HLA-DRB1—celiac disease	9.59e-05	0.00121	CbGpPWpGaD
Erlotinib—ABL1—Immune System—PTPN2—celiac disease	9.46e-05	0.00119	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CCR3—celiac disease	9.41e-05	0.00118	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—LCT—celiac disease	9.34e-05	0.00118	CbGpPWpGaD
Erlotinib—EGFR—Immune System—MBL2—celiac disease	9.33e-05	0.00117	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—SH2B3—celiac disease	9.21e-05	0.00116	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—HLA-DQB1—celiac disease	9.1e-05	0.00114	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CD80—celiac disease	8.86e-05	0.00112	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD8A—celiac disease	8.49e-05	0.00107	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RGS1—celiac disease	8.46e-05	0.00107	CbGpPWpGaD
Erlotinib—EGFR—Immune System—FCGR2A—celiac disease	8.43e-05	0.00106	CbGpPWpGaD
Erlotinib—MKNK1—Disease—CD4—celiac disease	8.28e-05	0.00104	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TNFAIP3—celiac disease	8.28e-05	0.00104	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HLA-DPB1—celiac disease	8.27e-05	0.00104	CbGpPWpGaD
Erlotinib—EGFR—Immune System—PTPN2—celiac disease	8.09e-05	0.00102	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LCT—celiac disease	7.92e-05	0.000996	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CTLA4—celiac disease	7.84e-05	0.000987	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CD80—celiac disease	7.79e-05	0.00098	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CD80—celiac disease	7.6e-05	0.000956	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD79A—celiac disease	7.48e-05	0.000941	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-DPB1—celiac disease	7.07e-05	0.00089	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—HLA-DRB1—celiac disease	6.92e-05	0.000871	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HLA-DQA1—celiac disease	6.9e-05	0.000869	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CD4—celiac disease	6.77e-05	0.000851	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CTLA4—celiac disease	6.7e-05	0.000843	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CD80—celiac disease	6.66e-05	0.000838	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCR4—celiac disease	6.54e-05	0.000823	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HLA-DQB1—celiac disease	6.46e-05	0.000813	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD79A—celiac disease	6.39e-05	0.000804	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD80—celiac disease	6.39e-05	0.000804	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LCT—celiac disease	6.11e-05	0.000769	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD8A—celiac disease	6.03e-05	0.000759	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CD4—celiac disease	5.95e-05	0.000748	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-DQA1—celiac disease	5.9e-05	0.000742	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CD80—celiac disease	5.73e-05	0.000721	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCR3—celiac disease	5.56e-05	0.0007	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-DQB1—celiac disease	5.52e-05	0.000694	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SH2B3—celiac disease	5.42e-05	0.000682	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD8A—celiac disease	5.15e-05	0.000648	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CD4—celiac disease	5.08e-05	0.000639	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HLA-DRB1—celiac disease	4.91e-05	0.000618	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD4—celiac disease	4.88e-05	0.000614	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CD80—celiac disease	4.67e-05	0.000588	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD80—celiac disease	4.54e-05	0.000571	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-DRB1—celiac disease	4.2e-05	0.000528	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD80—celiac disease	3.88e-05	0.000488	CbGpPWpGaD
Erlotinib—EGFR—Disease—CD80—celiac disease	3.58e-05	0.00045	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD4—celiac disease	3.46e-05	0.000436	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD4—celiac disease	2.96e-05	0.000372	CbGpPWpGaD
Erlotinib—EGFR—Disease—CD4—celiac disease	2.73e-05	0.000344	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CD80—celiac disease	2.51e-05	0.000315	CbGpPWpGaD
